Budesonide multimatrix (MMX)
Indication
For induction of remission in adults with mild to moderate active ulcerative colitis where 5-ASA (aminosalicylate) treatment is not sufficient.
Induction of remission in patients with active microscopic colitis (MC).
Amber level 0
Brand:
Cortiment ®
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Gastro-intestinal system
Background
Budesonide MMX 9mg (Cortiment®) is recommended as an alternative to oral/topical corticosteroids, where these treatments are judged to be unsuitable or will cause unacceptable side effects, for the induction of remission in patients with mild to moderate active ulcerative colitis (UC) where 5‑ASA (aminosalicylate) treatment is not sufficient.
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: